From: Hormonal aspects of overtraining syndrome: a systematic review
Hormone | Quantity of studies | Normal response | Blunted response | Exacerbated response |
---|---|---|---|---|
Cortisol | 26 (65.0%) | 18 (69.2%) | 8 (30.8%) | - |
Total T | 18 (45.0%) | 14 (77.8%) | 3 (16.7%) | 1 (5.9%) |
GH | 13 (32.5%) | 7 (53.8%) | 5 (38.4%) | 1 (7.8%) |
T/C | 10 (25.0%) | 5 (50.0%) | 4 (40.0%) | 1 (10.0%) |
ACTH | 10 (25.0%) | 6 (60.0%) | 4 (40.0%) | - |
Plasma catecholamines | 9 (22.5%) | 4 (44.4%) | 4 (44.4%) | 1 (11.1%) |
Insulin | 8 (20.0%) | 6 (75.0%) | 2 (25.0%) | - |
LH | 8 (20.0%) | 7 (87.5%) | 1 (12.5%) | - |
Prolactin | 6 (15.0%) | 4 (66.7%) | 2 (33.3%) | - |
FSH | 6 (15.0%) | 5 (83.3%) | 1 (16.7%) | - |
IGF-1 | 5 (12.5%) | 3 (60.0%) | 1 (20.0%) | 1 (20.0%) |
Aldosterone | 5 (12.5%) | 1 (20.0%) | 2 (40.0%) | 2 (40.0%) |
Free T | 3 (7.5%) | 1 (33.3%) | 1 (33.3%) | 1 (33.3%) |
T4 | 2 (5.0%) | 2 (100%) | - | - |
T3 | 2 (5.0%) | 2 (100%) | - | - |
NUC | 2 (5.0%) | - | 2 (100%) | - |
Salivary C | 2 (5.0%) | - | 2 (100%) | - |
Salivary T | 2 (5.0%) | 1 (50.0%) | 1 (50.0%) | - |
NUC | 2 (5.0%) | 1 (50.0%) | 1 (50.0%) | - |
IGFBP-3 | 2 (5.0%) | 1 (50.0%) | 1 (50.0%) | - |
IGF-1/IGFBP-3 | 2 (5.0%) | 2 (100%) | - | - |
SHBG | 1 | 1 | - | - |
DHEA-S | 1 | 1 | - | - |
Peptide F | 1 | 1 | - | - |
Fertility | 1 | - | 1 | - |
Beta-2 muscle receptors | 1 | - | 1 | - |